Oud-Heverlee, Flemish Region, Belgium
Clinical Research Executive with a passion for innovation in our industry. The way clinical trials are executed is changing, triggered by the Covid pandemic, but fundamentally due to progress in technology and changes to data obtained for clinical subjects. We should embrace this shift since it will ultimately lead to better / more relevant data and more participation of patients regardless of where they are. For the CRO industry, which has in many ways reached full maturity this change will lead to different staffing requirements and ultimately a model less based on billing hours and more on obtaining the right datasets using all available sources and technologies. I am exited to play a role in this crucial field for healthcare, without innovation we will not achieve the progress in many therapeutic areas which still require solutions for unmet needs.
As CEO I am responsible for overall leadership, growth and financial performance of Julius Clinical. I work with the management team and the board to develop the strategic plan for Julius Clinical as a unique science driven CRO with global capabilities. At Julius Clinical we are linking scientific experts with excellent operational capabilities to be able to deliver clinical trial results in innovative and efficient ways. Our ability to convert strategy in real patient data is industry leading and adds value to Pharma, Biotech and independant investigators looking for optimal solutions for their development needs. Before joining Julius Clinical, I worked as Clinical Research executive in a number of CROs, most recently as COO of Chiltern.
Responsible for Global Operations at Julius Clinical. Working with clients and partners to achieve real innovative results. Member of the Management Team for Julius Clinical
Member of Chilterns Global Executive Board. Responsible for Chilterns Global Clinical Development and Global Scientific Solutions departments and as such leading the Global Operations Management Team.
Responsible for Chiltern's Global Clinical Development Operations covering Phase I - IV Services Member of the Chiltern Global Executive Board
Established a Global Project Management Department with dedicated managers working under Global SOPs based upon the PMBOK as published by the PMI Implementation of Operational and Financial Metrics in a CRO Environment
Responsible for the company's Project Management Department with staff in the US and Europe